Biogen Idec (BIIB -0.2%) says it's collaborating with several leading academic research centers...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen Idec (BIIB -0.2%) says it's collaborating with several leading academic research centers to leverage a range of scientific techniques and disciplines to identify new approaches to treating amyotrophic lateral sclerosis. It is anticipated that coordinating research and sharing results across a number of different disciplines will greatly accelerate the understanding of the mechanisms of the disease and the development of new treatments.